论文部分内容阅读
目的：观察灯盏花素治疗脑梗塞的疗效。方法：１８０例脑梗塞病人，其中男９５例，女８５例。年龄（６２±７３）ａ。采用灯盏花素注射液１０～２０ｍｌ加入生理盐水５００ｍｌ，静脉滴注，每天１次，１４ｄ为１疗程。隔２～３ｄ进行第２疗程。对照组１１０例，男６８例，女４２例。年龄（６１８±６８）ａ。采用低分子右旋糖酐５００ｍｌ静滴，方法、疗程同治疗组。结果：灯盏花素组总有效率８５％，显效率７３％。右旋糖酐组总有效率７０％，显效率３５％，经Ｒｉｄｉｔ分析：Ｐ＜００５。同时还显示灯盏花素对血脂、血液流变学均有显著改善（Ｐ＜００５）。该药不良反应少。结论：灯盏花素是治疗脑梗塞的良好药物。
Objective: To observe the efficacy of Breviscapine in the treatment of cerebral infarction. Methods: 180 cerebral infarction patients, including 95 males and 85 females. Age (62 ± 73) a. Using breviscapine injection 10 ~ 20ml added saline 500ml, intravenous infusion, 1 day, 14d for a course of treatment. After 2 ~ 3d for the second course of treatment. The control group of 110 cases, 68 males and 42 females. Age (618 ± 68) a. Low molecular dextran 500ml intravenous infusion, method, treatment with the treatment group. Results: Breviscapine total effective rate of 85%, markedly effective rate of 73%. Dextran group, the total effective rate 70%, markedly efficient 35%, Ridit analysis: P <0 05. Breviscapine also showed significant improvement in blood lipids and hemorheology (P <005). The drug adverse reactions. Breviscapine is a good drug for the treatment of cerebral infarction.